Vancouver
Originally published online as doi:10.1189/jlb.1007717 on March 10, 2008

Published online before print March 10, 2008
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.1007717v1
83/6/1522    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, A. J.
Right arrow Articles by Walsh, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, A. J.
Right arrow Articles by Walsh, G. M.
(Journal of Leukocyte Biology. 2008;83:1522-1529.)
© 2008 by Society for Leukocyte Biology

Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT1R antagonism

Alexander J. Robinson*, Dmitry Kashanin{dagger}, Frank O'Dowd{dagger}, Vivienne Williams{dagger} and Garry M. Walsh*,1

* School of Medicine, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and
{dagger} Cellix Ltd., Institute of Molecular Medicine, St. James Hospital, Dublin, Ireland

1Correspondence: School of Medicine, University of Aberdeen, Aberdeen, Scotland, United Kingdom, AB24 2ZD. E-mail: g.m.walsh{at}abdn.ac.uk

ABSTRACT

Montelukast (MLK) is a cysteinyl leukotriene receptor-1 (cysLT1R) antagonist with inhibitory effects on eosinophils, key proinflammatory cells in asthma. We assessed the effect of MLK on resting and GM-CSF-stimulated eosinophil adhesion to recombinant human (rh)VCAM-1 at different flow rates using our novel microflow system. At 1 or 2 dyn cm–2, shear-stress unstimulated eosinophils tethered immediately to rhVCAM-1, "rolled" along part of the channel until they tethered, or rolled without tethering. At flow rates greater than 2 dyn cm–2, adherent eosinophils began to be displaced from rhVCAM-1. MLK (10 nM and 100 nM) gave partial (~40%) but significant (P<0.05) inhibition of unstimulated eosinophil adhesion to rhVCAM-1 at 1 or 2 dyn cm–2 shear stress. Once adhered, unstimulated eosinophils did not exhibit morphological changes, and GM-CSF-stimulated eosinophil adhesion under flow was characterized by greater cell flattening with significant (P<0.05) inhibition of adherent cell numbers by 100 nM MLK observed. This effect appeared specific for MLK, as the analog (E)-3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-[[3-dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic acid, sodium salt, had no significant effect on eosinophil adhesion to VCAM-1. The possibility that LTC4, released from unstimulated or GM-CSF-treated eosinophils, contributed to their adhesion to VCAM-1 was excluded as the LT biosynthesis inhibitor 3-[1-(p-Chlorobenzyl)-5-(isopropyl)-3-t-butylthioindol-2-yl]-2,2-dimethylpropanoic acid had no inhibitory effect, and exogenously added LTC4 did not enhance eosinophil adhesion. In contrast, LTD4 enhanced eosinophil adhesion to VCAM-1, an effect blocked by MLK (10 and 100 nM). These findings demonstrate that MLK-mediated inhibition of unstimulated and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under shear-stress conditions appears independent of cysLT1R antagonism.

Key Words: asthma • migration • VLA-4